Nootropil (Piracetam)

Piracetam, the active ingredient in Nootropil, is a racetam presented as an oral tablet for oral use. It is prescribed to support cognitive function and is used in the management of certain neurological conditions such as cognitive impairment, dementia, myoclonus, and vertigo.

GNH USA supplies Nootropil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide, ensuring quality compliance with EU standards. The company handles regulatory documentation, batch release and logistics to meet the needs of global healthcare providers.

Piracetam is a racetam nootropic that influences neuronal function and is employed in several neurological conditions.

Cognitive impairment: enhances attention and memory performance in patients with age‑related or disease‑related decline. Dementia: may improve cognitive scores and daily functioning in certain types of dementia. Myoclonus: reduces the frequency and intensity of involuntary muscle jerks. Vertigo: alleviates dizziness episodes associated with vestibular dysfunction.

Piracetam is generally well tolerated, but adverse reactions have been reported.

Common Side Effects: - Headache: mild to moderate intensity. - Insomnia: difficulty initiating or maintaining sleep. - Nausea: occasional gastrointestinal discomfort. - Dizziness: transient light‑headedness. - Anxiety: increased nervousness or restlessness.

Serious or Rare Side Effects: - Allergic reactions: rash, pruritus, or angioedema. - Hematologic abnormalities: thrombocytopenia or leukopenia. - Severe psychiatric symptoms: agitation, hallucinations, or depression. - Seizures: rare occurrence, particularly in predisposed individuals. - Hepatic dysfunction: elevated liver enzymes.

When prescribing piracetam, clinicians should consider several precautionary measures to ensure patient safety. Renal function: assess and adjust use in patients with severe renal impairment. Elderly patients: monitor for confusion or worsening cognition. Pregnancy and lactation: insufficient data; avoid unless potential benefit justifies the risk. Concomitant CNS depressants: use with caution as additive effects may occur. Drug interactions: review all concurrent medications for possible interactions. Store at room temperature: keep in the original container, protect from moisture and light.

Piracetam may interact with other medicines, requiring attention to the level of interaction.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Antiepileptic drugs (e.g., carbamazepine): may reduce piracetam plasma concentrations.

Moderate Interactions (Monitor Closely): - Caffeine: can enhance stimulant effects and cause nervousness. - Alcohol: may increase central nervous system depression. - Other nootropics (e.g., aniracetam, oxiracetam): additive cognitive effects may require dose adjustment.